MarketPulse
Z

$ZBH

6 articles found
5 positive
1 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Mordor Intelligence

Tissue Engineering Market Poised to Nearly Double to $27.6B by 2031

Tissue engineering market projected to grow from $15.01B to $27.59B by 2031 at 12.95% CAGR, driven by regenerative medicine advances and 3D bioprinting innovation.
MDTSNNZBHORGOIARTregenerative medicinebiomaterials
GlobeNewswire Inc.GlobeNewswire Inc.··Healthcare Foresights

Surgical Drill Bits Market to Nearly Double to $540M by 2035

Global surgical drill bits market to grow from $316M in 2025 to $540M by 2035 at 5.5% CAGR, driven by infrastructure development and rising surgical volumes.
JNJSYKMDTSNNZBHsurgical instrumentsmedical devices
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Foot and Ankle Device Market Poised for 8% Growth Through 2034

Global foot and ankle devices market projected to surge from $5.9B in 2025 to $9.2B by 2034, driven by aging populations and diabetes complications.
JNJSYKSNNZBHmarket growthmedical devices
GlobeNewswire Inc.GlobeNewswire Inc.··Towards Healthcare

Ambulatory Surgical Equipment Market Eyes $14.58B by 2035 on 7.85% Growth

Global ambulatory surgical equipment market projected to double from $7.39B in 2026 to $14.58B by 2035, driven by demand for minimally invasive procedures.
JNJSYKMDTPHGGEHC+2market growthmedical devices
GlobeNewswire Inc.GlobeNewswire Inc.··Mordor Intelligence

Orthobiologics Market Set to Hit $9.5B by 2031 as Regenerative Medicine Surges

Global orthobiologics market projected to grow 43% to $9.52B by 2031, driven by rising osteoarthritis and regenerative therapy advancements.
JNJSYKMDTZBHBVS+1regenerative medicinestem cell therapy
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Zimmer Biomet Stock Plunges 15% as Guidance Cut Triggers Securities Fraud Probe

Zimmer Biomet stock fell 15.2% after cutting organic revenue guidance to 4.0% from 4.5%, citing emerging market weakness and U.S. revision slowdown. Securities investigation launched.
ZBHsecurities fraudstock decline